u/andres_dahlberg

fibrosis improvement without worsening steatohepatitis is the phrase to learn

vendor source pages link storefronts and the link is marked

do not import intuitions from the obesity programmes

Which network, exactly?

What is the plan if the drift continues for another month?

Pasted rather than typed the address, then checked the first and last six characters. Habit now.

Histological endpoints in this field are scored on biopsy: resolution of steatohepatitis without worsening of fibrosis, or improvement in fibrosis without worsening of steatohepatitis. Both are harder to achieve and to interpret than an imaging surrogate.

Independent purity data on this compound is sparse compared with the older molecules, simply because far fewer members have paid for testing. Sparse data means wide uncertainty, not a verdict.

do not chase the last two kilos with a dose increase

Correction: that trial measured regain after withdrawal, not failure of the drug during treatment. Very different claim.

That is a range, not a trend. Two weigh-ins 23 days apart cannot distinguish them.

the hepatic data is what makes this compound different from the others

rule-change proposals need a concrete wording, not a complaint

Submissions older than a year are archived: readable, linkable, and closed to new comments. That keeps a three-year-old thread from being reopened with a reply nobody will see in context.

Body weight varies by a couple of kilos over days in stable people through fluid, glycogen and gut content. A range is not a trend.

That is a complaint rather than a proposal. Bring wording and it can actually be discussed.

Stretching the interval, reducing the dose, or both?

transit_variance is right that stretching and reducing are different levers. Worth separating in every one of these threads.

independent testing on this compound is very thin

ask which networks they actually accept before you order

nobody here is paid, including the moderators

Agreed — concrete wording or it is not a proposal.

maintenance is where the logistics finally get boring, which is the point

Escrow is not standard in this space. Wanting it is reasonable; expecting it as default is not.

Yes — a proposal with concrete wording gets discussed. A complaint about the rules in general does not.

A token symbol identifies an asset, not a network. The same symbol commonly exists on several chains with incompatible address formats, and sending across that boundary is generally unrecoverable.

Kept a log purely because so few people are logging this one. It is one person and it is not data.

How many confirmations does it show?

The ranking functions are published: the hot ordering combines score magnitude with age, and the controversial ordering weights total volume by the balance between up and down votes. Both are reproducible from the numbers on each submission.

Did the address you sent to match the one you were given, character for character?

Correction: that trial measured regain after withdrawal, not failure of the drug during treatment. Very different claim.

That is a range, not a trend.

Agreed — and appetite is the leading indicator. The scale is the lagging one.

appetite returns before the scale acknowledges anything

Not convinced. Interval stretching changes your exposure profile, not just the total, and the two are not equivalent.

Agreed. The hepatic programme is the point of this compound and the weight discussion is a side effect of the side effect.

amylin analogue, different receptor family, different story

Agreed that a few kilos of drift is ordinary. Weight is not a fixed number even for people who have never taken anything.

The evidence standard on the vendor boards requires a document, a date or a named service behind any claim about a supplier.

Disagreeing with this bit: making individual cases public by default is worse for the person being moderated.

Careful, that address format belongs to a different chain and sending to it would not end well.

this board is small because the compound is early

Agreed that the endpoint definitions matter enormously and almost nobody reads them before quoting a response rate.

Yes. The habits have to outlive the dose or the maintenance phase is just a countdown.